Six-Month Outcome in Patients With Myocardial Infarction Initially Admitted to Tertiary and Nontertiary Hospitals fn1fn1This project was funded by Grant 92/0009 from the Fondo de Investigación Sanitaria, Madrid and by Grant CIRIT/SGR 9500167 from the Generalitat de Catalunya, Barcelona, Spain.fn2fn2To discuss this article on-line, visit the ACC Home Page at www.acc.org/membersand click on the JACC Forum  by Marrugat, Jaume et al.
Six-Month Outcome in Patients With Myocardial Infarction Initially
Admitted to Tertiary and Nontertiary Hospitals
JAUME MARRUGAT, MD, GINE´S SANZ, MD,* RAFEL MASIA´, MD,† VICENTE VALLE, MD,‡
LLUIS MOLINA, MD,§ MARIA CARDONA, MD,* JOAN SALA, MD,† LLUIS SERE´S, MD,‡
LLUIS SZESCIELINSKI, MD,§ XAVIER ALBERT, MD,† JOSEP LUPO´N, MD,‡
JORDI ALONSO, MD, FOR THE RESCATE INVESTIGATORS\
Barcelona and Girona, Spain
Objectives. The aim of the present study was to ascertain
whether the degree of accessibility to coronary angiography and
revascularization results in differing usages or outcomes, or both,
in the setting of a high coverage national health system.
Background. The selective use of coronary angiography and
revascularization procedures in the management of acute myocar-
dial infarction (MI) remains controversial.
Methods. A cohort of 1,460 consecutive patients with a first MI
admitted to four referral teaching hospitals (one with tertiary
facilities) were followed up for 6 months after admission. Only
patients initially admitted to each of the study hospitals were
retained for analysis in the original hospital’s cohort. End points
were 6-month mortality and readmission for reinfarction, unsta-
ble angina, heart failure or severe ventricular arrhythmia.
Results. Patients admitted to the tertiary hospital were more
likely to undergo coronary angiography (adjusted relative risk
4.22, 95% confidence interval [CI] 3.37 to 5.45) than those
admitted to the nontertiary sites (use rate: 22.1% for nontertiary
care, 55.5% for tertiary care). Revascularization procedures were
performed in 21.2% of patients in the tertiary hospital and in 8.3%
in the nontertiary hospitals (p < 0.0001). Median delay for
emergency coronary angiography was shorter in the tertiary
hospital (within 1 vs. 2 days, p < 0.0001). Six-month mortality or
readmission rates were similar (23.7% and 24.7% for tertiary and
nontertiary care, respectively). After adjustment for comorbidity
and disease severity, the relative risk of death or readmission for
the tertiary hospital was 1.03 (95% CI 0.69 to 1.53) times that of
the nontertiary hospitals.
Conclusions. Selective use of coronary angiography and revas-
cularization procedures may be as effective as less restricted use
in the management of acute MI.
(J Am Coll Cardiol 1997;30:1187–92)
©1997 by the American College of Cardiology
The prognosis of patients admitted for acute myocardial
infarction (MI) has progressively improved in the past 30 years,
due mainly to the development of coronary care units (1) and
the use of thrombolytic therapy (2,3) and other pharmacologic
treatments (4,5). However, the optimal use rate of tertiary care
procedures, such as coronary angiography, coronary artery
bypass graft surgery (CABG) (6) and percutaneous translumi-
nal coronary angioplasty (PTCA) (7), has not been established.
Marked geographic variations in use rate have been described
(8,9), and on-site availability is one of the strongest predictors
of their use (10). It remains to be determined whether re-
stricted use of such procedures results in worse patient out-
come. Retrospective studies (11,12) suggest that a high use
rate of tertiary procedures does not result in better survival,
although anginal symptoms may be reduced and quality of life
and functional status at 1 or 2 years improved.
The Spanish National Health System covers .97% of the
population (13); thus, hospital treatment does not depend on
the patient’s ability to pay.
The aims of the present study were to ascertain whether the
variation in accessibility to coronary angiography, PTCA and
CABG, depending on the in-hospital availability of these
procedures, determines different use rates or delays in patients
with MI and to assess whether these differences, if existent, are
associated with differences in outcome.
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Methods
Study design. The study was designed as a 6-month
follow-up study of patients admitted to one hospital with and
three without angiography or coronary surgery facilities. All
four participating hospitals were public teaching institutions.
Patients admitted to the tertiary care hospital were referred to
as group A and those admitted to the nontertiary hospitals as
group B. The tertiary hospital included exclusively primarily
admitted patients; thus, patients referred from group B hospi-
tals were not included. Patients from group B hospitals were
referred to several tertiary hospitals in Barcelona for angio-
graphic procedures, and each patient outcome was attributed
to the initial admitting hospital.
Inclusion criteria. Between May 1992 and June 1994, all
patients with a first MI up to the age of 80 years admitted to
the four participating hospitals within 72 h of onset of symp-
toms of MI were included. MI was diagnosed when two of the
following criteria were present: 1) abnormal new Q waves, 2)
increase in cardiac enzyme levels (more than twice the upper
normal value), and 3) typical chest pain .20 min in duration.
Exclusion criteria. Residence outside the study areas or
any of the following conditions: 1) life-threatening diseases
other than the index event; 2) previous CABG or PTCA; 3) or
coronary angiography in the past 6 months. Patients enrolled
in ongoing clinical trials were not excluded to reproduce actual
care scenarios more faithfully.
Primary end points. The composite primary end point
included mortality or readmission within 6 months of the onset
of MI for any of the following reasons: 1) reinfarction, 2)
congestive heart failure, 3) ventricular fibrillation or tachycar-
dia, or 4) unstable angina. Reinfarction was defined as a new
infarction occurring at least 28 days after the onset of the initial
event. Congestive heart failure was diagnosed clinically accord-
ing to standard diagnostic criteria (14,15). Ventricular tachycar-
dia was considered an end point only when sustained and
leading to hospital admission. Progressive and rest angina were
considered unstable angina, therefore requiring hospital admis-
sion according to Braunwald criteria (16).
Sample size. Sample size was chosen to obtain a statistical
power of 0.80 in a two-tailed test with an alpha risk of 0.05 if
a difference $10 percentage points in the 6-month event rate
was observed between the tertiary and the nontertiary hospi-
tals (20% and 30% of primary end points, respectively). A 10%
increase in the intended sample was applied to compensate for
patients lost to follow-up; thus, 1,300 patients were required, of
whom at least 325 had to be admitted to Hospital A. This
sample size would permit a relative risk $1.5 to be statistically
significant (p , 0.05).
Management of MI. Each participating hospital was al-
lowed to follow its own routine, and no attempt was made to
standardize patient management. However, all four hospitals
had written MI protocols in accordance with international
guidelines (17–19).
Appropriateness of procedures. Emergency indications for
coronary angiography, PTCA and CABG were standardized in
advance to assess the need for their urgent use. These criteria
were adapted from specific international treatment guide-
lines (17–19). Emergency coronary angiography was considered
appropriate in the presence of 1) recurrent episodes of angina,
particularly if accompanied by ST-T wave changes, not con-
trolled after 48 h of appropriate treatment; or 2) mechanical
complications, including severe mitral regurgitation due to
papillary muscle dysfunction or ventricular septal rupture.
Emergency revascularization was considered appropriate in
either of the aforementioned circumstances when coronary
anatomy was deemed suitable. CABG was preferred to PTCA
in patients with left main coronary artery stenosis or diffuse
coronary disease (two to three vessels) or when cardiac repair
was necessary. Patients with one- or two-vessel discrete lesions
were judged to be candidates for PTCA.
The need for elective angiography was assessed in detail in a
random subsample half the total sample size. This procedure
was considered necessary if at least one of the following
occurred: 1) postinfarction angina, 2) mechanical complica-
tions, 3) positive exercise test results, or 4) reinfarction within
28 days.
Study variables in acute phase of MI. The following vari-
ables were prospectively recorded by a trained investigator at
each center: demographic data; history of hypertension; dia-
betes; chronic obstructive pulmonary disease; peripheral
vascular disease; smoking status; MI location; Killip class;
presence of severe arrhythmia (defined as the occurrence of
at least one episode of ventricular fibrillation or sustained
ventricular tachycardia requiring immediate medical inter-
vention) within the first 72 h; delay from onset of symptoms
to first monitoring in an emergency room, coronary care unit
or general intensive care unit; and hospital stay, use of
thrombolysis, exercise test, coronary angiography, PTCA and
CABG and the complications associated with diagnostic and
therapeutic procedures.
Analysis and statistical methods. Groups A and B were
assessed for differences in categoric variables by the chi-square
or Fisher exact test when appropriate and by the Student t or
Mann-Whitney U test when necessary for differences in con-
tinuous variables. The level of significance used was 5%.
Survival curves were estimated by the Kaplan-Meier
method. Adjusted relative risks for 6-month mortality and
morbidity were estimated using unconditional logistic regres-
sion (20). Severity or prognosis-related variables showing
interhospital differences were adjusted for in the models to
control for case mix. All two-level interactions between pairs of
these variables were assessed in all models. The SPSS and
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CI 5 confidence interval
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary angioplasty
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EGRET (Statistics and Epidemiology Research Corporation)
statistical packages were used.
Results
Patients. Of the 2,397 patients registered in the four
hospitals, 1,460 (60.8%) (1,035 initially admitted to nontertiary
hospitals, 425 to tertiary hospital) met the inclusion criteria.
Previous MI (18.4%) and age .80 years (9.6%) were the most
frequent reasons for exclusion. Other causes included patients
residing outside the hospital catchment area, which made
follow-up impractical (4.5%); previous revascularization
(1.0%); and angiography in the previous 6 months (0.3%). An
additional 5.8% were excluded for miscellaneous reasons, such
as administrative; terminal, severe noncoronary disease; and
referral from participant hospitals.
Patients admitted to the three group B hospitals did not
differ clinically or statistically in any relevant characteristic
(results not shown).
Differences in some demographic and clinical variables
were found between groups A and B (Table 1). The group A
hospital (the only tertiary site) more frequently admitted
patients with comorbidity (i.e., diabetes and hypertension),
non-Q wave MI or previous angina than did the group B
hospitals. Conversely, patients in group B were more often in
Killip class III or IV than patients in group A.
Procedures. Median delays to first cardiac monitoring were
similar in groups A and B. More than 50% of patients
performed an exercise test. Thrombolytic therapy was admin-
istered in 545 patients (37.4%) (Table 2), with a median time
from symptom onset to administration of 3 h. Streptokinase
was the drug of choice in 77.8% of occasions.
Coronary angiography was performed in 463 patients
(31.8%), PTCA in 93 (6.5%) and CABG in 83 (5.7%) within 6
months of admission. By the end of the follow-up period, the
tertiary hospital had performed more coronary angiography
than the nontertiary hospitals (55.5% vs. 22.1%, p , 0.0001),
and the use rate of elective angiography was higher in the
tertiary hospital (50.1% vs. 14.9%, p , 0.0001) (Table 2). In
the random subsample, these procedures were deemed neces-
sary in 40.7% of patients in the tertiary hospital and 39.6% in
the nontertiary hospitals (p 5 NS). The proportion of patients
who underwent revascularization was higher in group A than in
group B (PTCA: 12.0% vs. 4.1%, respectively, p , 0.0001;
CABG: 9.2% vs. 4.3%, respectively, p 5 0.0002; PTCA or
CABG: 21.0% vs. 8.3%, respectively, p , 0.0001) (Table 2).
In a model adjusted for age, Killip class, gender, diabetes,
hypertension, MI location, Q wave MI and previous angina,
the relative risk for coronary angiography use among patients
in group A versus group B was 4.22 (95% confidence interval
[CI] 3.27 to 5.45). Use rate of angiography in patients with a
non-Q wave MI was 1.34 (95% CI 0.97 to 1.99) times that of
patients with a Q wave MI.
Complications. Complications occurring during the 6-
month period were death (one patient [0.3%]), MI (four
patients), stroke (two patients) and surgical femoral artery
repair (six patients) for coronary angiography; death (one
patient) (1.4%) and surgical repair (one patient) for PTCA;
and death (three patients [4.7%]), MI (one patient) and stroke
(one patient) for CABG.
Appropriateness and delay in urgent procedure use. Rates
of emergency coronary angiography and revascularization
Table 1. Demographic and Clinical Characteristics of Study Patients
Admitted to Tertiary (group A) and Nontertiary Hospitals (group B)
Group A
(n 5 425)
Group B
(n 5 1,035)
p
Value
Age (yr) 62.5 6 11.1 61.9 6 11.3 NS
Women 23.1 22.5 NS
Killip class III or IV 9.9 15.4 0.0060
Anterior MI 29.5 31.5 NS
Non-Q wave MI 23.8 14.4 , 0.0001
Arrhythmia* 8.5 9.8 NS
COPD 20.3 17.6 NS
Diabetes 34.5 28.1 0.0160
Hypertension 51.3 45.5 0.0461
PVD 12.6 10.9 NS
Smoker† 48.5 47.6 NS
Previous angina 47.8 35.4 , 0.0001
*Ventricular fibrillation within 72 h of onset of symptoms of myocardial
infarction (MI). †At least 1 cigarette/day. Data presented are mean value 6 SD
or percent of patients. COPD 5 chronic obstructive pulmonary disease; PVD 5
peripheral vascular disease.
Table 2. Time to Coronary Care Unit Admission, Length of
Hospital Stay and Use of Coronary Angiography and
Revascularization Procedures by Hospital Type
Group A
(tertiary hospital)
(n 5 425)
Group B
(nontertiary
hospitals)
(n 5 1,035)
p
Value
Time from symptom onset to
monitoring (h)
Median 2.6 2.3 NS
Range 0 to ,24 0 to ,24
Time from symptom onset to
CCU admission (h)
Median 6.7 7.5 0.0104
Range 0.8 to 72 0.4 to 72
CCU stay (days)
Median 4 5 , 0.0001
Range 1 to 37 1 to 60
Hospital stay (days)
Median 13 10 , 0.0001
Range 1 to 137 1 to 96
Thrombolysis 36.2 37.9 NS
Exercise test 55.3 58.4 NS
6-mo follow-up
Elective coronary angio 50.3 14.9 , 0.0001
PTCA 12.0 4.1 , 0.0001
CABG 9.2 4.3 0.0002
Data presented are percent of patients, unless otherwise indicated. angio 5
angiography; CABG 5 coronary artery bypass graft surgery; CCU 5 coronary
care unit; PTCA 5 percutaneous transluminal coronary angioplasty.
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techniques according to hospital type are shown in Table 3.
Ninety-six patients (6.4%) met objective criteria for emergency
coronary angiography, which was eventually performed in 77
(80.8%).
No differences between groups were observed in the pro-
portion of patients in whom PTCA was indicated or per-
formed. In 19 patients, emergency coronary angiography was
indicated but not performed: In 2 of these 19 it was not
requested by the attending physician (both patients were alive
at the end of the 6-month follow-up period). Of the remaining
17 patients, 12 rapidly deteriorated and died before the
procedure could be performed. In five patients referred by
nontertiary hospitals, coronary angiography was not performed
by the receiving tertiary hospital (four patients were alive at
end of the 6-month follow-up).
Among the 76 patients with emergency indication for
coronary angiography, the proportion of patients meeting
emergency criteria for PTCA or CABG and the proportion of
patients who finally underwent these procedures was similar in
both groups. The median delay in performing emergency
catheterization was shorter in the tertiary hospital than in the
nontertiary hospitals (within 1 vs. 2 days, respectively, p ,
0.001) (Table 3).
Outcome. Both 28-day and 6-month mortality and readmis-
sion rates for both groups are shown in Table 4. Only two
patients were lost to follow-up. Overall intergroup differences
in mortality or readmission rate were not statistically signifi-
cant. Survival curves in both groups were similar and not
statistically significant (Fig. 1).
Logistic regression models adjusted for differences between
groups A and B (Table 5) show that hospital type was not an
independent risk factor for 6-month mortality or readmission.
The relative risk in group B was 0.97 (95% CI 0.68 to 1.55). No
statistically significant interaction terms were identified. No
differences between groups were found when only 6-month
mortality was considered as a dependent variable. The relative
risk for group B was 1.12 (95% CI 0.83 to 1.51). No statistically
significant interaction terms were identified (Table 5).
Discussion
The results of the present study show that the use of tertiary
procedures in patients with a first acute MI varies according to
the type of admitting hospital. Although no differences were
found in the proportion of patients undergoing emergency
diagnostic or therapeutic procedures, longer delays were en-
countered in patients admitted to nontertiary hospitals. Fur-
thermore, admission to an institution with on-site cardiac
Figure 1. Survival probability for tertiary (dashed curve) versus non-
tertiary hospitals (solid curve) (p 5 0.98).
Table 3. Emergency Coronary Angiography and Revascularization
Within 28 Days of Onset of Myocardial Infarction in Patients
Meeting Standardized Criteria for These Procedures in Tertiary
(group A) and Nontertiary Hospitals (group B)
Group A
(n 5 425)
Group B
(n 5 1,035)
p
Value
Urgent angiography
Pts meeting criteria 22 (5.2%) 74 (7.2%) NS
Performed 20 57 NS*
Delay†
Median 0 2 , 0.0001
Range 0–0 0–62
Urgent PTCA
Pts meeting criteria 3 (0.7%) 11 (1.1%) NS
Performed 3 10 NS*
Delay†
Median 0 0 NS
Range 0–0 0–22
Urgent CABG
Pts meeting criteria 17 (4.0%) 26 (2.5%) NS
Performed 14 17 NS*
Delay†
Median 1 0 NS
Range 0–11 0–55
*Fisher exact test. †Mann-Whitney U test. Data presented are number (%)
of patients, unless otherwise indicated. Abbreviations as in Table 2.
Table 4. Primary End Points During Follow-Up in Study Patients
Admitted to Tertiary (group A) or Nontertiary Hospitals (group B)
Group A
(n 5 425)
Group B
(n 5 1,035)
p
Value
Death
Overall 6 mo 60 (14.2) 147 (14.2) NS
28 day 44 (10.4) 110 (10.6) NS
6 mo* 16 (4.2) 37 (4.0) NS
Readm*
Reinfarction 11 (2.9) 35 (3.9) NS
Angina 25 (6.6) 64 (7.0) NS
VF/VT 1 (0.3) 15 (1.6) 0.0512
Cardiac failure 12 (3.2) 40 (4.4) NS
Any of above 43 (11.7) 127 (14.0) NS
Death or Readm 99 (23.7) 252 (24.7) NS
*Among 28-day survivors. Data presented are number (%) of patients.
Readm 5 hospital readmission; VF/VT 5 ventricular tachycardia/ventricular
fibrillation.
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catheterization facilities was strongly associated with the use of
coronary angiography. However, no differences were found in
the 6-month mortality or readmission rate between the tertiary
and the three nontertiary hospitals, even after adjustment for
severity and comorbidity variables.
These results raise the question of whether differences in
use reflect an excess in the number of procedures performed in
the tertiary hospital. Several attempts have been made to
assess the consequences of differences in acute coronary
syndrome management, with inconclusive results (21–23).
Large geographic variations in procedure use rate have also
been described, which indicates that some use may be inap-
propriate (8,24,25). One study suggests that 30% of CABG
may be performed for equivocal reasons and that 14% are
inappropriate (26) and another that low risk patients are
selected for angiography and revascularization (27). Interest-
ingly, in our study the proportion of patients with objective
indications for emergency coronary angiography, PTCA and
CABG was similar in both hospital types, although longer
delays were observed in the nontertiaries. Therefore, the
differences observed in utilization rates were due to the larger
number of elective procedures carried out in the tertiary
hospital. Again, the proportion of elective angiograms deemed
necessary was similar in both types of hospitals when it was
investigated in a random subsample. Patients admitted to
hospitals with on-site cardiac catheterization facilities are more
likely to undergo coronary angiography than patients admitted
to other hospitals (10). The results of our study concur with
that finding, also confirmed by others (27,28). The greater
number of patients with non-Q wave MI admitted to the
tertiary hospital may in part account for the higher use of
elective angiography.
In addition to availability, financial incentives and patient
demand have been suggested as factors influencing variations
in the use of tertiary procedures in patients with coronary
disease (11). Hospitals in the Spanish National Health System
do not provide financial incentives for physicians to perform
procedures. It is therefore highly unlikely that financial reasons
accounted for the differences observed in our study.
Study characteristics and limitations. The finding that
outcome was similar in both hospital types and was unrelated
to the use of invasive procedures is in accordance with
previously reported results (11). The present study was specif-
ically designed and powered to detect differences in event rates
between tertiary and nontertiary hospitals. The observation
period was extended to 6 months, when most of the events
related to the acute phase of MI would already have occurred.
However, according to the results of previous studies (11,12),
a longer observation period might reveal differences in anginal
symptoms or functional status.
The present study did not address other issues related to
on-site unavailability of tertiary care procedures, such as
inconvenience and distress for patients transferred between
hospitals and their relatives.
The following measures were taken to ensure efficient case
mix control: Only patients with a first MI were included;
exclusions and their causes had to be justified; and statistical
adjustment for case mix (i.e., differences in disease severity and
comorbidity between the two hospital types) was used. To
prevent physician-dependent outcomes, PTCA or CABG after
discharge was not used as an end point.
Conclusions. Our results suggest that despite longer delays
and probably more inconvenience to patients, the selective use
of coronary angiography and revascularization procedures
applied in nontertiary centers is as effective as the less re-
stricted use observed in tertiary hospitals.
We appreciate the English revision of the manuscript made by Christine O’Hara.
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